This work presents a customized and configurable solution for the online monitoring and diagnosis of power transformers that is already installed in the field and provides the main diagnostics of the ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

A WebAssembly-based JSON Logic evaluator with custom operators for feature flag evaluation. Designed to work with Chicory (pure Java WebAssembly runtime) and other WASM runtimes.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the overlooked penny stocks to invest in. On January 12, Alec Stranahan, an analyst at Bank of America Securities, maintained a Hold rating on ...

ABSTRACT: Enterprise application integration encounters substantial hurdles, particularly in intricate contexts that require elevated scalability and speed. Transactional applications directly ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Overprovision can be seen as an architecture strategy through the lens of resilience—making spaces adaptable to changes, reinterpretations, and future needs. However, could overprovision also offer a ...

Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's potentially revolutionary approach has yet to produce results. The stock's upside is enormous if ...

Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech company focused on artificial intelligence (AI), went public in April 2021. This was before ChatGPT, before AI became the hottest topic on Wall ...

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...